Literature DB >> 1490944

Energy status of the rapidly paced canine myocardium in congestive heart failure.

C Montgomery1, N Hamilton, C D Ianuzzo.   

Abstract

Rapid ventricular pacing (RVP) is used as an experimental model of congestive heart failure (CHF). The purpose of this study was to determine the energy status of the dog myocardium after the development of CHF via chronic RVP. The myocardium had a significantly lower (P < 0.05) energy charge (EC) during CHF (0.63 +/- 0.01) than in sham-operated controls (0.82 +/- 0.02). This was due to significant differences in concentrations in ATP (-48%), ADP (29%), and AMP (275%) in the RVP group. However, the total adenine nucleotide pool was not different between groups. Myocardial lactate concentration was also similar. Glycogen was significantly lower (P < 0.05) by 20% at peak CHF. The adenine nucleotides were similar among the different myocardial layers (endo-, mid-, and epicardium). The administration of enalapril (an inhibitor of angiotension-converting enzyme) to decrease vascular resistance had no effect on the myocardial energy status of CHF dogs. These findings suggest that the lower EC in CHF animals is not the result of subendocardial ischemia. Also, lower EC is not associated with endogenous glycogen depletion or increased lactate concentration. The energy status of the myocardium in RVP-induced CHF is unlike that seen in ischemia-induced heart failure. This suggests that CHF in RVP is not vascular in origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490944     DOI: 10.1152/jappl.1992.73.6.2363

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Characterization of Cardiac Troponin Elevation in the Setting of Pediatric Supraventricular Tachycardia.

Authors:  Jeremy P Moore; Lisa Arcilla; Shuo Wang; Michael S Lee; Kevin M Shannon
Journal:  Pediatr Cardiol       Date:  2015-10-19       Impact factor: 1.655

2.  Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function.

Authors:  Andrea M Cordero-Reyes; Anisha A Gupte; Keith A Youker; Matthias Loebe; Willa A Hsueh; Guillermo Torre-Amione; Heinrich Taegtmeyer; Dale J Hamilton
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

3.  Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts.

Authors:  Fan Wu; Eric Y Zhang; Jianyi Zhang; Robert J Bache; Daniel A Beard
Journal:  J Physiol       Date:  2008-07-10       Impact factor: 5.182

4.  On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.

Authors:  D J Pennell; J P Carpenter; M Roughton; Zi Cabantchik
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-12       Impact factor: 5.364

5.  Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study.

Authors:  Junko Shibayama; Tatiana N Yuzyuk; James Cox; Aman Makaju; Mickey Miller; Justin Lichter; Hui Li; Jane D Leavy; Sarah Franklin; Alexey V Zaitsev
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 6.  Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.

Authors:  Vincenzo Mollace; Giuseppe M C Rosano; Stefan D Anker; Andrew J S Coats; Petar Seferovic; Rocco Mollace; Annamaria Tavernese; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Jessica Maiuolo; Roberta Macrì; Francesca Bosco; Marcello Chiocchi; Francesco Romeo; Marco Metra; Maurizio Volterrani
Journal:  Nutrients       Date:  2021-01-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.